AAPS PharmSciTech

, Volume 16, Issue 1, pp 165–170 | Cite as

Development of a Material Sparing Bulk Density Test Comparable to a Standard USP Method for Use in Early Development of API’s

  • Helen Hughes
  • Michael M. Leane
  • Michael Tobyn
  • John F. Gamble
  • Santiago Munoz
  • Pauline Musembi
Research Article

Abstract

Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API’s can be expensive and the availability of material for powder property analysis is limited. The aim of this work was to investigate a suitable small-scale, low material requirement, bulk density test which would provide comparable data to the recommended large volume USP test. Materials with a range of morphological characteristics typically seen in the pharmaceutical industry were assessed to ensure that methods were suitably robust. It was found that the USP II “low volume” test does not give equivalent results to other tests in the USP, across the range of materials. An alternative test based on the FT4 powder rheometer at a scale of 25 mL gave results equivalent to the large volume USP I standard test. The use of smaller 10-mL methods was also found to give acceptable results for materials that were considered well-behaved but were more variable with difficult to handle materials with low bulk density.

KEY WORDS

active pharmaceutical ingredient (API) bulk density compressibility index excipients pharmaceuticals 

Notes

Acknowledgements

The team is grateful for the help of Peter Timmins, Venkatramana Rao, and Joanne Kelleher in executing this work.

References

  1. 1.
    Mohammadi MS, Harnby N. Bulk density modelling as a means of typifying the microstructure and flow characteristics of cohesive powders. Powder Technol. 1997;92(1):1–8.CrossRefGoogle Scholar
  2. 2.
    Iacocca RG, Burcham CL, Hilden LR. Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development. J Pharm Sci. 2010;99(1):51–75.PubMedCrossRefGoogle Scholar
  3. 3.
    United States Pharmacopeia and National Formulary. USP 36-NF 31. Rockville: United States Pharmacopeia Convention; 2013. p. 265–7.Google Scholar
  4. 4.
    Vasilenko A, Koynov S, Glasser BJ, Muzzio FJ. Role of consolidation state in the measurement of bulk density and cohesion. Powder Technol. 2013;239:366–73.CrossRefGoogle Scholar
  5. 5.
    Sousa e Silva JP, Splendor D, Gonçalves IMB, Costa P, Sousa Lobo JM. Note on the measurement of bulk density and tapped density of powders according to the European pharmacopeia. AAPS Pharm Sci Technol. 2013;14(3):1098–100.CrossRefGoogle Scholar
  6. 6.
    Durney TE, Meloy TP. Particle shape effects due to crushing method and size. Int J Miner Process. 1986;16(1–2):109–23.CrossRefGoogle Scholar
  7. 7.
    Rawle AF. Particle morphology and characterization in preformulation. In: Adeyeye MC, Brittain HG, editors. Preformulation in solid dosage form development: Informa Healthcare; 2008. p. 145–84.Google Scholar
  8. 8.
    Leane MM, Sinclair W, Qian F, Haddadin R, Brown A, Tobyn M, et al. Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant. Pharm Dev Technol. 2013;18(2):359–66.PubMedCrossRefGoogle Scholar
  9. 9.
    Crouter A, Briens L. The effect of moisture on the flowability of pharmaceutical excipients. AAPS Pharm Sci Technol. 2014;15(1):65–74.CrossRefGoogle Scholar
  10. 10.
    Gamble JF, Chiu WS, Tobyn M. Investigation into the impact of sub-populations of agglomerates on the particle size distribution and flow properties of conventional microcrystalline cellulose grades. Pharm Dev Technol. 2011;16(5):542–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Leturia M, Benali M, Lagarde S, Ronga I, Saleh K. Characterization of flow properties of cohesive powders: a comparative study of traditional and new testing methods. Powder Technol. 2014;253:406–23.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2014

Authors and Affiliations

  • Helen Hughes
    • 1
  • Michael M. Leane
    • 1
  • Michael Tobyn
    • 1
  • John F. Gamble
    • 1
  • Santiago Munoz
    • 2
  • Pauline Musembi
    • 1
  1. 1.Drug Product Science and TechnologyBristol-Myers SquibbMoretonUK
  2. 2.Global Manufacturing and SupplyBristol-Myers SquibbSwordsIreland

Personalised recommendations